Bernstein Harold
Known title: President, R&D & CMOCIK: 0002050172
Associated companies
Transaction History
| MAZE | ▲ Buy | Option Exercise | 16,141 | $168K | 10/1/2026 | View on chart |
| MAZE | ▼ Sell | Open Market | 16,141 | $435K | 10/1/2026 | View on chart |
| MAZE | ▼ Sell | Open Market | 9,705 | $255K | 9/4/2026 | View on chart |
| MAZE | ▼ Sell | Open Market | 5,130 | $133K | 9/3/2026 | View on chart |
| MAZE | ▼ Sell | Open Market | 59 | $2K | 9/3/2026 | View on chart |
| MAZE | ▼ Sell | Open Market | 4,481 | $118K | 9/2/2026 | View on chart |
| MAZE | ▼ Sell | Open Market | 625 | $17K | 9/2/2026 | View on chart |
| MAZE | ▲ Buy | Option Exercise | 16,141 | $168K | 9/1/2026 | View on chart |
| MAZE | ▲ Buy | Option Exercise | 20,000 | $0 | 9/1/2026 | View on chart |
| MAZE | ▼ Sell | Open Market | 16,141 | $426K | 9/1/2026 | View on chart |
| MAZE | ▲ Buy | Option Exercise | 16,142 | $168K | 8/13/2026 | View on chart |
| MAZE | ▼ Sell | Open Market | 16,142 | $446K | 8/13/2026 | View on chart |
| MAZE | ▲ Buy | Option Exercise | 14,609 | $152K | 7/1/2026 | View on chart |
| MAZE | ▼ Sell | Open Market | 13,409 | $400K | 7/1/2026 | View on chart |
| MAZE | ▼ Sell | Open Market | 1,200 | $36K | 7/1/2026 | View on chart |
| MAZE | ▲ Buy | Option Exercise | 14,853 | $155K | 6/1/2026 | View on chart |
| MAZE | ▼ Sell | Open Market | 13,253 | $339K | 6/1/2026 | View on chart |
| MAZE | ▼ Sell | Open Market | 1,600 | $42K | 6/1/2026 | View on chart |
| MAZE | ▲ Buy | Option Exercise | 15,000 | $156K | 5/14/2026 | View on chart |
| MAZE | ▼ Sell | Open Market | 15,000 | $393K | 5/14/2026 | View on chart |
| MAZE | ▲ Buy | Option Exercise | 15,000 | $156K | 4/1/2026 | View on chart |
| MAZE | ▼ Sell | Open Market | 11,352 | $332K | 4/1/2026 | View on chart |
| MAZE | ▼ Sell | Open Market | 3,348 | $101K | 4/1/2026 | View on chart |
| MAZE | ▼ Sell | Open Market | 300 | $9K | 4/1/2026 | View on chart |
| MAZE | ▲ Buy | Option Exercise | 15,000 | $156K | 3/20/2026 | View on chart |
| MAZE | ▼ Sell | Open Market | 6,161 | $297K | 3/20/2026 | View on chart |
| MAZE | ▼ Sell | Open Market | 3,795 | $187K | 3/20/2026 | View on chart |
| MAZE | ▼ Sell | Open Market | 5,044 | $252K | 3/20/2026 | View on chart |
| MAZE | ▲ Buy | Option Exercise | 30,000 | $313K | 3/10/2026 | View on chart |
| MAZE | ▼ Sell | Open Market | 29,652 | $1.5M | 3/10/2026 | View on chart |
| MAZE | ▼ Sell | Open Market | 348 | $18K | 3/10/2026 | View on chart |
| MAZE | ▲ Buy | Option Exercise | 15,000 | $156K | 2/2/2026 | View on chart |
| MAZE | ▼ Sell | Open Market | 600 | $27K | 2/2/2026 | View on chart |
| MAZE | ▼ Sell | Open Market | 8,364 | $384K | 2/2/2026 | View on chart |
| MAZE | ▼ Sell | Open Market | 5,936 | $275K | 2/2/2026 | View on chart |
| MAZE | ▼ Sell | Open Market | 100 | $5K | 2/2/2026 | View on chart |
| MAZE | ▲ Buy | Option Exercise | 25,156 | $262K | 1/7/2026 | View on chart |
| MAZE | ▼ Sell | Open Market | 25,156 | $1.0M | 1/7/2026 | View on chart |
| MAZE | ▲ Buy | Option Exercise | 412 | $4K | 1/5/2026 | View on chart |
| MAZE | ▼ Sell | Open Market | 412 | $16K | 1/5/2026 | View on chart |
| MAZE | ▲ Buy | Option Exercise | 4,432 | $46K | 1/2/2026 | View on chart |
| MAZE | ▼ Sell | Open Market | 4,432 | $179K | 1/2/2026 | View on chart |
| MAZE | ▲ Buy | Option Exercise | 45,000 | $469K | 12/29/2025 | View on chart |
| MAZE | ▼ Sell | Open Market | 27,800 | $1.1M | 12/29/2025 | View on chart |
| MAZE | ▼ Sell | Open Market | 17,200 | $704K | 12/29/2025 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Pompe Disease Market Expected to Grow Through 2036
A new market report projects expansion in the Pompe Disease sector from 2026 to 2036, driven by next-generation enzyme replacement therapies and pipeline innovation. This industry growth is relevant to Maze Therapeutics, which operates in this therapeutic area. The report highlights broader market trends rather than company-specific financial results.
Pompe Disease Market Expected to Grow Through 2036. A new market report projects expansion in the Pompe Disease sector from 2026 to 2036, driven by next-generation enzyme replacement therapies and pipeline innovation. This industry growth is relevant to Maze Therapeutics, which operates in this therapeutic area. The report highlights broader market trends rather than company-specific financial results.